Best Testicular Cancer Hospital in Hyderabad — 11 Centres, NCCN Protocols, NABH-Accredited Partners

Testicular cancer surgery should be performed by a urologic oncologist — a specialist trained in cancers of the urinary system and male reproductive organs. The orchiectomy itself is technically demanding because it must be performed via the correct approach (through the groin, not the scrotum) to avoid spreading cancer cells. Around the urologic oncologist, the team needs a medical oncologist specifically experienced with the BEP chemotherapy regimen used for advanced testicular cancer (this regimen requires careful management of dose timing, hydration, and side effects to deliver safely), a radiation oncologist for selected seminoma cases, a pathologist with germ cell tumour expertise, a reproductive specialist for sperm banking arrangements, and an endocrinologist for cases where both testicles are removed or hormone replacement is needed.

A testicular cancer tumour board reviews the scrotal ultrasound, the tumour marker results (AFP, beta-hCG, LDH — these are critical for both diagnosis and follow-up because rising markers indicate residual or recurrent disease), the CT scans, and the histological findings from the orchiectomy. The board assigns a stage and matches it to the right treatment: Stage I disease often goes onto active surveillance after orchiectomy; Stage II disease typically gets chemotherapy or radiation depending on tumour type; Stage III gets chemotherapy. Equally important, the board discusses fertility preservation before any treatment that could affect future fertility begins.

Testicular cancer surgery and chemotherapy are highly protocolised but require specific experience. The orchiectomy through the groin is technically straightforward for experienced urologic oncologists but should not be done by surgeons unfamiliar with the cancer principles. The BEP chemotherapy regimen used for advanced testicular cancer is one of the most curative regimens in oncology but also one that requires careful management — proper hydration to protect the kidneys from cisplatin, monitoring for bleomycin lung toxicity, dose timing without gaps that could allow the cancer to escape. Centres with more experience generally deliver these regimens more safely. Ask: “How many testicular cancer cases did your team manage last year? How many BEP chemotherapy courses?”

Diagnosis starts with scrotal ultrasound (painless, takes a few minutes) and tumour marker blood tests for AFP, beta-hCG, and LDH. The tumour markers serve three purposes: they help confirm the diagnosis, they help stage the cancer (high markers suggest more advanced disease), and they are followed during and after treatment to ensure the cancer has been eradicated. CT of the chest, abdomen, and pelvis is the standard staging imaging — checking for spread to lymph nodes (particularly the retroperitoneal lymph nodes deep in the abdomen, which testicular cancer commonly spreads to first), the lungs, and other organs. MRI is used in selected cases.

Sperm banking before any treatment starts is one of the most important things a hospital does for young men with testicular cancer — and it should never be left for the patient to ask about. Removing one testicle (orchiectomy) doesn't usually cause infertility because the remaining testicle produces sperm. But the chemotherapy regimens used for advanced disease can significantly affect fertility, sometimes permanently. Sperm banking is a simple, quick process — usually one or two clinic visits — but the window is before treatment, not after. A hospital that handles testicular cancer properly raises this conversation at the first consultation, arranges referral to a reproductive specialist, and ensures the patient has a clear opportunity to bank sperm before any chemotherapy.

Radical inguinal orchiectomy is a relatively short operation but must be performed correctly — the inguinal approach (through a small groin incision) is essential rather than the scrotal approach (which can spread cancer cells through scrotal lymph drainage). For some non-seminoma cases, retroperitoneal lymph node dissection (RPLND) — removal of the lymph nodes deep in the abdomen behind the bowel — is performed by experienced urologic surgeons. This is a more major operation requiring appropriate facilities and post-operative care. NABH-accredited partners signal audited surgical safety.

Testicular cancer treatment costs vary substantially by stage. For Stage I disease on active surveillance, costs are largely from imaging surveillance over years. For advanced disease, chemotherapy and possible RPLND add up significantly. Sperm banking is typically a self-pay service (not usually covered by insurance) but its cost is modest relative to the long-term value. A hospital that isn't empanelled for your insurance or ArogyaSri at the specific centre where your treatment happens can derail planning.

Two distinctive aspects of testicular cancer survivorship deserve attention. First, active surveillance for Stage I disease is a legitimate, evidence-based option that requires strict discipline — regular tumour markers, regular CT scans, regular clinical reviews on a defined schedule for at least 5 years. About 80–85% of Stage I patients are cured by orchiectomy alone and never need further treatment; the 15–20% who relapse during surveillance are caught early and cured with chemotherapy at that point. Second, late-effects monitoring matters because survivors live for many decades — cisplatin chemotherapy carries small but real long-term risks of cardiovascular disease, secondary cancers, hearing loss, and peripheral neuropathy.

Hospital infrastructure for testicular cancer is tiered at CION. Scrotal ultrasound, tumour marker testing, CT staging, day-care chemotherapy, surveillance imaging, late-effects monitoring, and clinical reviews happen at the centre nearest your home. Radical inguinal orchiectomy and retroperitoneal lymph node dissection when needed run through NABH-accredited partner hospitals with verified urologic oncology expertise. The same oncology team that consults at one centre stays with you across the network.

Sperm banking before any treatment that could affect fertility is part of CION's standard testicular cancer pathway — it is not a question patients have to think to ask. At the first consultation, for any young man being worked up for testicular cancer, the fertility conversation happens explicitly. Where the patient agrees, referral to a reproductive specialist is arranged before the orchiectomy if there is time, or before chemotherapy begins for cases where chemotherapy follows surgery. Sperm samples are collected and frozen for future use in fertility treatments. The conversation also includes long-term financial considerations of storage. For young men who may not yet have started families, this single conversation can make the difference between future biological children being possible or not.

For Stage I testicular cancer (confined to the testicle, no spread on imaging or in tumour markers), active surveillance is offered as the modern preferred option after orchiectomy. The patient is monitored on a strict schedule — tumour markers and CT scans at defined intervals for at least 5 years — and most patients are cured by orchiectomy alone. For the minority who relapse during surveillance, chemotherapy is started immediately and is highly effective. This pathway requires patient discipline (the surveillance schedule cannot be casual) and CION's commitment to long-term, structured follow-up. For more advanced stages, BEP chemotherapy or radiation therapy is delivered according to standard NCCN protocols.

Tumour markers (AFP, beta-hCG, LDH) are central to testicular cancer care from diagnosis to long-term surveillance. CION monitors markers at the standard intervals — pre-treatment, during chemotherapy, after completion, and then on the long-term surveillance schedule. Rising markers during follow-up are the earliest sign of recurrence and trigger immediate further imaging and intervention. This kind of structured biomarker monitoring is something a generic urology service is unlikely to deliver with the same discipline.

All 11 CION centres in Hyderabad have day-care infusion bays. The BEP chemotherapy regimen (bleomycin, etoposide, cisplatin) — the curative standard for advanced testicular cancer — is administered with the careful attention this protocol requires: pre-hydration before cisplatin to protect the kidneys, monitoring of pulmonary function for bleomycin lung toxicity, anti-nausea management, and disciplined dose timing. The oncology nursing team is experienced specifically with this regimen.

Testicular cancer survivors live for many decades after treatment — meaning the long-term effects of cisplatin chemotherapy (small but real risks of cardiovascular disease, secondary cancers, hearing loss, peripheral neuropathy, and reduced fertility) need to be monitored over the long term. CION's testicular cancer survivorship pathway includes scheduled cardiovascular risk assessment, hearing assessment for patients who received platinum chemotherapy, peripheral neuropathy monitoring, hormonal monitoring, and surveillance for second cancers.

Every testicular cancer case at CION is also reviewed by the multidisciplinary tumour board before the treatment plan is finalised. The board reviews the ultrasound, tumour markers, CT staging, and histological findings; assigns the stage; decides on the post-orchiectomy approach (active surveillance, chemotherapy, radiation, or RPLND); confirms fertility preservation has been raised; and plans surveillance. The board produces a written summary that becomes part of your records — and yours to keep.